Advertisement

BCNP Consultants European Chemistry Partnering 2017 Ffm Germany 600x60px
Document › Details

Thermo Fisher Scientific Inc.. (7/26/10). "Press Release: Thermo Fisher Scientific Highlights Innovation in Clinical Research and Specialty Diagnostics at AACC 2010. Simplified Workflow for Immunosuppressant Analysis Saves Time and Improves Results". Wal

Region Region Anaheim, CA
  Country United States (USA)
Organisations Organisation Thermo Fisher Scientific Inc. (NYSE: TMO)
  Group Thermo Fisher (Group)
  Organisation 2 American Association for Clinical Chemistry (AACC)
Products Product ClinSpec Immunosuppressant Test Kit
  Product 2 Versette automated liquid handling platform
Person Person Casper, Marc N. (Thermo Fisher 200910– CEO before 200805– COO joined Thermo 12/01 before Kendro CEO before Dade Behring)
     


Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, will highlight its innovative offering of products and services for clinical research and specialty diagnostics during the American Association for Clinical Chemistry (AACC) Annual Meeting and Clinical Lab Expo held in Anaheim, California, July 25 - 29, 2010.

Thermo Fisher will introduce a substantially improved liquid chromatography/mass spectrometry (LC/MS) workflow for immunosuppressant analysis designed to improve productivity in clinical research applications. The seamless integration of instruments, software, consumables and reagents significantly reduces sample preparation time, improves overall performance and provides a total workflow supported by a single supplier. This workflow will be adapted to the analysis of a number of drugs, as well as vitamins and steroids. For more information, visit Booth 2415 at the Anaheim Convention Center.

"This year at AACC, we are highlighting how our scale and depth of capabilities are meeting increasing demand in clinical research and specialty diagnostics markets," said Marc N. Casper, president and chief executive officer of Thermo Fisher Scientific. "Building on the strength of our highly recognized brands for clinical research and combining them into an easy-to-use workflow demonstrates for our customers the benefit of working with a single, comprehensive supplier."

Thermo Fisher's focus at this year's AACC meeting is on advancements in both sample preparation and analysis. The company's innovative workflow combines automated sample preparation, a fully contained immunosuppressant test kit, as well as industry-leading LC/MS technology and columns specifically designed for clinical research.

The Thermo Scientific ClinSpec Immunosuppressant Test Kit, for example, provides all the reagents, standards, controls and sample preparation methodology needed to monitor immunosuppressant drugs during research. The kit is part of a total solution for immunosuppressant drug analysis and was developed to provide significant time savings when compared with manual sample preparation. Similarly, the Thermo Scientific Versette automated liquid-handling platform is used to simplify the sample-handling method, whether the research chemist is transitioning from handheld pipetting or establishing an integrated system.

For more information about Thermo Fisher's products and services for clinical research and specialty diagnostics, visit http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.thermofisher.com%2Faacc2010&esheet=6371143&lan=en-US&anchor=www.thermofisher.com%2Faacc2010&index=1&md5=351f7650ea44a8ca207206620f96e1e9.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science. Our mission is to enable our customers to make the world healthier, cleaner and safer. With revenues of more than $10 billion, we have approximately 35,000 employees and serve customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as in environmental and process control industries. We create value for our key stakeholders through two premier brands, Thermo Scientific and Fisher Scientific, which offer a unique combination of continuous technology development and the most convenient purchasing options. Our products and services help accelerate the pace of scientific discovery, and solve analytical challenges ranging from complex research to routine testing to field applications. Visit http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.thermofisher.com%2F&esheet=6371143&lan=en-US&anchor=www.thermofisher.com&index=2&md5=71e682777cd47b6f3f6057e389635a3d.

Thermo Fisher Scientific Inc.

Media: Ron O'Brien, 781-622-1242
ron.obrien@thermofisher.com

or

Investor: Ken Apicerno, 781-622-1294
ken.apicerno@thermofisher.com

   
Record changed: 2016-03-19

Advertisement

Picture EBD Group BIO-Europe Spring 2017 BES Barcelona Spain March 600x60px

More documents for Thermo Fisher (Group)


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture EBD Group BIO-Europe Spring 2017 BES Barcelona Spain March 600x60px




» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px BCNP Consultants European Chemistry Partnering 2017 Ffm Germany 120x180px Picture EBD Group BIO-Europe Spring 2017 BES Barcelona Spain March 120x180px Picture AB Sciex Berliner LCMSMS Symposium 2017 Right 120x80px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px